• Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers

  • May 23 2024
  • Length: 1 hr and 30 mins
  • Podcast
Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers cover art

Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers

  • Summary

  • Featuring perspectives from Ms Blanca Ledezma, Dr Stacey Stein, Ms Amanda K Wagner and Dr Mark Yarchoan, including the following topics:

    • Introduction (0:00)
    • Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma (HCC) (9:40)
    • Role of Immunotherapy in Intermediate-Stage HCC (17:02)
    • First-Line Therapy for Advanced HCC (19:56)
    • Immunotherapy in the Management of Advanced Biliary Tract Cancers (BTCs) (44:29)
    • Biomarker Testing Recommendations and the Use of FGFR Inhibitors for Advanced Cholangiocarcinoma (58:02)
    • Potential Role of HER2-Targeted Therapy for BTCs (1:17:16)

    CME information and select publications

    Show more Show less

What listeners say about Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.